| 1 |
McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schönlein purpura [J]. Eur J Pediatr,2010, 169(6): 643-650.
|
| 2 |
Saulsbury FT. Henoch-Schönlein purpura [J]. Curr Opin Rheumatol, 2010, 22(5): 598-602.
|
| 3 |
Coppo R, Mazzucco G, Cagnoli L, et al. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura [J]. Nephrol Dial Transplant, 1997, 12(11):2277-2283.
|
| 4 |
解放军肾脏病研究所学术委员会 .过敏性紫癜性肾炎诊断及规范 [J].肾脏病与透析肾移植杂志, 2004, 13(4): 358-359.
|
| 5 |
Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch-Schonle in nephritis [J]. Pediatr Nephrol，2010, 25(6): 1101-1108.
|
| 6 |
张格妙, 方琪玮, 岳满红. 盐酸贝那普利治疗小儿过敏性紫癜肾炎蛋白尿应用研究 [J]. 山西医药杂志, 2008, 37(7): 647-648.
|
| 7 |
Tylicki L, Renke M, Rutkowski P, et al. Randomized controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis [J].Med Sci Monit，2005, 11(4): 31-37
|
| 8 |
Coppo R, Peruzzi L, Amore A.et al. IgACE: a placebocontrolled,randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria [J]. J Am Soc Nephrol, 2007, 18(6): 1880-1888.
|
| 9 |
Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized,double-blind, placebo-controlled trial [J]. J Pediatr, 2006, 149(2):241-247
|
| 10 |
Lv J, Zhang H, Chen Y, et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial [J]. Am J Kidney Dis, 2009, 53(1): 26-32.
|
| 11 |
Foster BJ, Bernard C, Drummond KN, et al.Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study [J]. J Pediatr,2000, 136(3): 370-375.
|
| 12 |
Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis[J]. Pediatr Nephrol, 1998, 12(3): 238-243.
|
| 13 |
Tarshish P, Bernstein J, Edelmann Jr CM. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide [J]. Pediatr Nephrol, 2004, 19(1): 51-56.
|
| 14 |
Jauhola O, Ronkainen J, Autio-Harmainen H, et al .Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial [J]. Pediatr Nephrol, 2011, 26(12): 2159-2166.
|
| 15 |
Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy [J]. Clin Nephrol, 1998, 49(1): 9-14.
|
| 16 |
Du Y, Hou L, Zhao C, et al. Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil [J].Pediatr Nephrol, 2012, 27(5): 765-771.
|
| 17 |
Buchanec J, Galanda V, Beláková S,et al.Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids [J]. Int Urol Nephrol, 1988, 20(4): 409-412
|
| 18 |
Chartapisak W, Opastirakul S, Hodson EM, et al. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP) [J]. Cochrane Database Syst Rev, 2009, 8(3):CD005128.
|
| 19 |
Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al.Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome [J]. Arthritis Rheum,1997, 40(5): 859-864.
|
| 20 |
Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults [J]. Am J Kidney Dis, 2006, 47(6): 993-1003.
|
| 21 |
Pillebout E, Thervet E, Hill G, et al. Henoch-Schonlein Purpura in adults:outcome and prognostic factors [J]. J Am Soc Nephrol,2002, 13(5): 1271-1278.
|
| 22 |
Pillebout E, Alberti C, Guillevin L, et al.Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura [J]. Kidney Int, 2010, 78(5): 495-502.
|